Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI037219-03
Application #
2073879
Study Section
Special Emphasis Panel (SRC (58))
Project Start
1994-09-30
Project End
1999-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Maecker, H T; Hansen, G; Walter, D M et al. (2001) Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 166:959-65
Deng, J; Yeung, V P; Tsitoura, D et al. (2000) Allergen-induced airway hyperreactivity is diminished in CD81-deficient mice. J Immunol 165:5054-61
McCormick, A A; Kumagai, M H; Hanley, K et al. (1999) Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci U S A 96:703-8
Maecker, H T; Umetsu, D T; DeKruyff, R H et al. (1998) Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J Immunol 161:6532-6
Maecker, H T; Umetsu, D T; DeKruyff, R H et al. (1997) DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 15:1687-96
Kim, T S; DeKruyff, R H; Rupper, R et al. (1997) An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 158:4137-44
Umetsu, D T; DeKruyff, R H (1997) TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 100:1-6
Umetsu, D T; DeKruyff, R H (1997) Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med 215:11-20
Marshall, J D; Secrist, H; DeKruyff, R H et al. (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155:111-7